ARCHIVES

General Says HHS Shift of Breast Cancer funds Could Leave Army in “Untenable Position”

This article is from The Cancer Letter archive.

Vol. 19 No. 11 | March 12, 1993

Download PDF Visit The Full Archive

Related Articles

Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards

October 28, 1983

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Carbone Heads Chairmen’s Group

June 30, 1978

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014